Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Protein expression systems

a protein and expression system technology, applied in the field of protein expression systems, can solve the problems of reducing the fermentation efficiency of the production of the desired recombinant, unable to survive host cells lacking the selection marker, such as revertants, and unable to achieve the production of superior host cells. , to achieve the effect of improving the production of bacteria's protein

Inactive Publication Date: 2005-08-25
PFENEX
View PDF10 Cites 126 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0020] It has been discovered that bacterial protein production can be improved by selecting as a host cell a Pseudomonad organism that is capable of non-antibiotic resistant, auxotrophic selection, and / or contains a chromosomal insert of a lacI gene or derivative.
[0022] It has also been surprisingly discovered that the use of a LacI-encoding gene other than as part of a whole or truncated Plac-lacI-lacZYA operon in Pseudomonads surprisingly resulted in substantially improved repression of pre-induction recombinant protein expression, higher cell densities in commercial-scale fermentation, and higher yields of the desired product in comparison with previously taught lacI-lacZYA Pseudomonad chromosomal insertion (U.S. Pat. No. 5,169,760). This lacI insertion is as effective in repressing Plac-Ptac family promoter-controlled transgenes as a multi-copy plasmid encoding a LacI repressor protein in Pseudomonas fluorescens, thereby eliminating the need to maintain a separate plasmid encoding a LacI repressor protein in the cell and reducing potential production inefficiencies caused by such maintenance.

Problems solved by technology

There are many hurdles to the creation of a superior host cell.
Such revertants can decrease the fermentation efficiency of the production of the desired recombinant polypeptide.
Host cells lacking the selection marker, such as revertants, are unable to survive.
The use of selection markers during the fermentation process is intended to ensure that only bacteria containing the expression vector survive, eliminating competition between the revertants and transformants and reducing the efficiency of fermentation.
The presence of antibiotic resistance genes in a bacterial host cell, however, presents environmental, regulatory, and commercial problems.
For example, antibiotic resistance gene-containing products (and products produced by the use of antibiotic resistance gene) have been identified as potential biosafety risks for environmental, human, and animal health.
Clearance of these agents, and especially demonstrating such clearance, is expensive, time consuming, and often only minimally effective.
For example, auxotrophic markers have been widely utilized in yeast, due largely to the inefficiency of antibiotic resistance selection markers in these host cells.
However, yeast expression systems due not provide the potential speed and efficiency for producing target proteins that bacterial systems do.
The use of auxotrophic selection markers in the previously described commercial scale bacterial fermentation systems has drawbacks that limit their use.
A major drawback, as noted in U.S. Pat. No. 6,413,768, is that nutritional auxotrophic selection marker systems generally suffer from cross feeding.
Because cross feeding allows revertant bacteria to survive, cross feeding decreases the overall capacity of the fermentation process to produce the desired product at efficient and maximized levels due to the presence of fewer target protein producing host cells.
Another hurdle to the creation of the ideal host cell is the inefficient and low level production of target polypeptides in the fermentation process.
In many cases, however, repression of expression of the target protein during cell growth can be imperfect, resulting in a significant amount of expression prior to the particular induction phase.
This “leaky” repression results in host cell stress, inefficient utilization of carbon source due to metabolic energy being diverted from normal cell growth to transgene, and a delay in reaching optimal cell density induction points, resulting in a more lengthy and costly fermentation run, and often, a reduced yield of the target protein.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Protein expression systems
  • Protein expression systems
  • Protein expression systems

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of a pyrF Selection Marker System in a P. fluorescens Host Cell Expression System

[0279] Reagents were acquired from Sigma-Aldrich (St. Louis Mo.) unless otherwise noted. LB is 10 g / L tryptone, 5 g / L yeast extract and 5 g / L NaCI in a gelatin capsule (BIO 101). When required, uracil (from BIO101, Carlsbad Calif.) or L-proline was added to a final concentration of 250 ug / mL, and tetracycline was added to 15 ug / mL. LB / 5-FOA plates contain LB with 250 mM uracil and 0.5 mg / mL 5-fluoroorotic acid (5-FOA). M9 media consists of 6 g / L Na2HPO4, 3 g / L KH2PO4, 1 g / L NH4Cl, 0.5 g / L NaCl, 10 mM MgSO4, 1× HoLe Trace Element Solution, pH7. Glucose was added to a final concentration of 1%. The 1000× HoLe Trace Element Solution is 2.85 g / L H3BO3, 1.8 g / L MnCl2 . 4H2O, 1.77 g / L sodium tartrate, 1.36 g / L FeSO4. 7H2O, 0.04 g / L CoCl2. 6H2O, 0.027 g / L CuCl2. 2H2O, 0.025 g / L Na2MoO4. 2H2O, 0.02 g / L ZnCl2.

Oligonucleotides Used Herein

[0280]

MB214pyrF1 (NotI site in bold)5′-GCGGCCGCTTTGGCGCTTCGT...

example 2

Construction of a pyrF—proC Dual Auxotrophic Selection Marker System in a P. fluorescens Host Cell Expression System

[0292] Oligonucleotides Used Herein

proC15′-ATATGAGCTCCGACCTTGAGTCGGCCATTG-(SEQ ID NO: 22)3′proC25′-ATATGAGCTCGGATCCAGTACGATCAGCAGG(SEQ ID NO: 23)TACAG-3′proC35′-AGCAACACGCGTATTGCCTT-3′(SEQ ID NO: 24)proC55′-GCCCTTGAGTTGGCACTTCATCG-3′(SEQ ID NO: 25)proC65′-GATAAACGCGAAGATCGGCGAGATA-3′(SEQ ID NO: 26)proC75′-CCGAGCATGTTTGATTAGACAGGTCCTTATT(SEQ ID NO: 27)TCGA-3′proC85′-TGCAACGTGACGCAAGCAGCATCCA-3′(SEQ ID NO: 28)proC95′-GGAACGATCAGCACAAGCCATGCTA-3′(SEQ ID NO: 29)genF25′-ATATGAGCTCTGCCGTGATCGAAATCCAGA-(SEQ ID NO: 30)3′genR25′-ATATGGATCCCGGCGTTGTGACAATTTACC-(SEQ ID NO: 31)3′XbaNotDraU2 linker5′-TCTAGAGCGGCCGCGTT-3′(SEQ ID NO: 32)XbaNotDraL linker5′-GCGGCCGCTCTAGAAAC-3′(SEQ ID NO: 33)

Cloning of proC from P. fluorescens and Formation of a pCN Expression Plasmid Containing proC

Replacing Antibiotic Resistant Gene in pCN51lacI with proC

[0293] The proC ORF and about 100 bp of...

example 3

Chromosomal Integration of lacI. lacIQ and lacIQ1 in P. fluorescens

[0316] Three P. fluorescens strains have been constructed, each with one of three different Escherichia coli lacI alleles, lacI (SEQ ID NO:9), lacIQ (SEQ ID NO: 11), and lacIQ1 (SEQ ID NO:12), integrated into the chromosome. The three strains exhibit differing amounts of LacI repressor accumulation. Each strain carries a single copy of its lacI gene at the levansucrase locus (SEQ ID NO:13) of P. fluorescens DC36, which is an MB101 derivative (see TD Landry et al., “Safety evaluation of an α-amylase enzyme preparation derived from the archaeal order Thermococcales as expressed in Pseudomonas fluorescens biovar I,”Regulatory Toxicology and Pharmacology 37(1): 149-168(2003)) formed by deleting the pyrF gene thereof, as described above.

[0317] No vector or other foreign DNA sequences remain in the strains. The strains are antibiotic-resistance-gene free and also contain a pyrF deletion, permitting maintenance, during gr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Nucleic acid sequenceaaaaaaaaaa
Login to View More

Abstract

The present invention provides an improved expression system for the production of recombinant polypeptides utilizing auxotrophic selectable markers. In addition, the present invention provides improved recombinant protein production in host cells through the improved regulation of expression.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority to U.S. Provisional patent application Ser. No. 60 / 523,420 filed Nov. 19, 2003, entitled “Improved Pseudomonas Expression Systems with Auxotrophic Selection Markers,” and U.S. Provisional patent application 60 / 537,147 filed Jan. 16, 2004, and entitled “Bacterial Expression Systems with Improved Repression.”FIELD OF THE INVENTION [0002] The present invention provides an improved expression system for the production of recombinant polypeptides utilizing auxotrophic selectable markers. In addition, the present invention provides improved recombinant protein production in host cells through the improved regulation of expression. BACKGROUND OF THE INVENTION [0003] The use of bacterial cells to produce protein based therapeutics is increasing in commercial importance. One of the goals in developing a bacterial expression system is the production of high quality target polypeptides quickly, efficiently, and abu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N1/21C12N9/06C12N9/88C12N15/52C12N15/74C12N15/78C12P13/22C12P21/00C12P21/02
CPCC12N9/0028C12N9/88C12P21/02C12N15/78C12P21/00C12N15/52C12Y305/05001C12N1/20
Inventor SCHNEIDER, JANECHEW, LAWRENCEBADGLEY, ANNERAMSEIER, THOMAS
Owner PFENEX
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products